333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA
Market cap: $33.0M (12/21/2025)
Price: $0.90
RenovoRx Enters $3.7M Capital on Demand Sales Agreement with JonesTrading
Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update
Financial Results, Other Events
Shareholder votes
Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
Earnings Release
Q3
Q1
Notice of Late Filing for Annual Report
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload
S-8 POS